Research priorities

Research priorities of Infectious and Tropical Diseases Research Center - 2020
 
- Study of HIV and opportunistic infections in the province
- Evaluation of drug resistant tuberculosis (diagnosis and treatment)
Evaluation of Mycobacterium tuberculosis infection (frequency, diagnosis and treatment)
- Prevalence and serological and molecular evaluation of CCHF and dengue hemorrhagic fevers
Evaluation of new diagnostic methods in infectious diseases
- Prevalence of UTI in patients referred to Bu Ali Hospital
- Prevalence of lung infections, influenza in the province
- Evaluation of drug resistance to common infectious diseases
Epidemiology of common infectious diseases in the region including tuberculosis, Congo fever, brucellosis, malaria, hepatitis
- Study of nosocomial infections in hospitals of Zahedan University of Medical Sciences
- Evaluating the timeliness and acceptability of the TB care system in the province
- Designing an Internet-based care system for tuberculosis
- Study of geographical distribution of malaria in the province
- The effect of using reminders in the form of text messages via staff mobile phones to follow the instructions for treatment of malaria
Crimean Congo Fever Care System Minimum Data Set
Evaluation of tuberculosis and malaria care systems in the province
Evaluation of drug resistance in hydatid cyst
- Evaluation of the effects of herbal nanoemulsions in comparison with existing drugs in the treatment of hydatid cyst
Evaluation of the effects of liposomes containing plant derivatives in the treatment of hydatid cyst
- Evaluation of drug resistance in malaria
- Evaluation of the effects of herbal nanoemulsions in comparison with existing drugs in the treatment of malaria
- Evaluation of the effects of liposomes containing plant derivatives in the treatment of malaria
- Evaluation of the effects of herbal nanoemulsions in comparison with existing drugs in the treatment of tuberculosis
- Evaluation of the effects of liposomes containing plant derivatives in the treatment of tuberculosis
- Evaluation of strategies for prevention and control of acute respiratory infections of influenza (education, vaccines, crisis management)
- Evaluation of the function of fine dust on the respiratory (pulmonary) system
Investigation of virulence factors of important pathogenic bacteria (E.Coli, Klebsiella, Salmonella, Shigella, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus, Enterobacter, Vibrio cholerae, Helicobacter pylori, Mycobacterium mycobacterium and Mycobacterium mycobacterium ...
- Investigation of molecular epidemiology of important pathogenic bacteria (mentioned in the first paragraph) with molecular methods such as pulse field, MLST, VLST, VNTR, RFLP, ribotyping, etc.
- Evaluation of phenotypic and genotypic drug resistance of important pathogenic bacteria (mentioned in the first paragraph) against antibiotics
- Design and production of new antibacterial drugs
- Design and production of vaccines (recombinant protein vaccines, DNA Vaccine, VLP and vector vaccines) for important pathogenic bacteria (mentioned in the first paragraph) by cloning and expression methods and ..
Evaluation of virulence factors and drug resistance of atypical pneumonia-causing bacteria (Mycoplasma, Chlamydia and L-Forms)
- Designing new methods of vaccination and drug delivery using nanoparticles
- Epidemiological study (phenotypic and genotypic diagnosis of factors, frequency, routes of transmission, etc.) hospital-acquired infections and outbreaks caused by microorganisms
- Review of methods to prevent nosocomial infections
- Phenotypic and genotypic study of recurrent and emerging bacterial agents (identification, frequency, drug resistance, epidemiology, etc.)
- Review, design and evaluation of new educational methods to improve the teaching of medical microbiology courses
- Investigation of bacterial agents (identification, frequency, prevention) of contaminants in laboratory samples received in different hospital wards
Investigating the role of bacteria in autoimmune diseases, cancers, MS and Alzheimer's
- Study and invention of new diagnostic methods for microorganisms
- Evaluation (frequency, methods of diagnosis and treatment, association with cancer, etc.) of different genotypes of papillomaviruses in women
Seroepidemiological study of arboviruses (CCHF, dengue fever, etc.) in high-risk groups
Molecular study of possible mutations and phylogenetic evaluation of circulating seasonal influenza viruses
- Prevalence of Blood borne viruses (HBV, HCV, HDV, HIV) in the general population and high-risk groups such as injecting drug users and ...
- Study (prevalence, treatment methods, association with transplant rejection, association with cancer, etc.) important human herpes viruses such as CMV, EBV, etc. in the general population and high-risk groups
- Design and manufacture of vaccines for important human pathogenic viruses (HCV, HIV, CCHF, Influenza, etc.)
- Designing new diagnostic methods for important viral infections (papilloma, influenza, viral hepatitis agents, CCHF, HIV, etc.)
Evaluation of inhibitory vaccines in malaria
Production of recombinant antigens for evaluation and screening of malaria, Toxoplasma and Leishmania
- Genotyping of Blastocystis hominis, Toxoplasma, Malaria and Cryptosporidium parasites
- Evaluation of new diagnostic methods in infectious diseases
- Evaluation of effective treatment methods in infectious diseases (chemical, nanoparticles and plant)
- Epidemiological study of emerging and reappearing diseases
Evaluation of the presence and prevalence of intestinal and emerging parasites in patients with AIDS, transplantation and cancer by parasitological, serological and molecular methods 


Research plans and priorities of the center

Related Content